Virtual meetings of its Vaccines and Related Biological Products Advisory Committee VRBPAC Announcement
Coronavirus (COVID-19) Update: FDA Announces Tentative Advisory Committee Meeting Schedule Regarding COVID-19 Vaccines
SILVER SPRING, Md., April 29, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is announcing its plans to hold virtual meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) in anticipation of complete submissions of emergency use authorization (EUA) requests in the coming months that have been publicly announced by COVID-19 vaccine manufacturers.